Veracyte Announces New Data at ASCO 2021 Reinforcing Prognostic Utility of Decipher Prostate Genomic Classifier

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veraycte (VCYT) announced that new data from studies of the company's Decipher Prostate Genomic Classifier will be presented at ASCO 2021.

Click to view original post